Strategic Investment

Former USAA CEO Wayne Peacock joins Cotality's board, signaling a strategic push to lead the AI-driven property data and insurance analytics market.

Struggling biotech Jupiter Neurosciences presents its Parkinson's drug to elite investors at Mar-a-Lago, betting its hybrid business model can win funding.

With a new CEO at the helm and a pivotal trial for its lead drug on the horizon, all eyes are on PureTech's upcoming investor conference presentation.

As AI agents and non-human identities multiply, Hush Security's new platform aims to replace risky static secrets with unified, identity-based access.

Ahead of its 2026 blockbuster film, Mattel unveils a massive publishing blitz aimed at transforming Masters of the Universe into a multi-generational saga.

Unnatural Products inks a major deal with Novartis, using its AI-driven macrocycle technology to develop novel cardiovascular drugs for intractable diseases.

UK brand Aurelia Cellular Vitality launches in the US, betting its science-led Eternacell™ complex can disrupt the booming ingestible beauty industry.

Vast's first NASA-backed mission to the ISS is a key step in the race to build private space stations before the iconic outpost retires in 2031.

A new 'longevity center' in Naperville signals a growing trend in proactive health, but what does this mean for the Chicago wellness landscape?

Known for men's shorts, Chubbies makes a splash with Cheekies, a new women's swim brand led by an all-female team. Can it succeed in a crowded market?

Stallion Uranium begins its high-stakes drilling program on an untested corridor, betting on advanced geology to find a major uranium deposit.

With $18M in grants, Reed Jobs's Yosemite uses a novel blend of philanthropy and VC to bridge critical funding gaps in the fight against cancer.

A new index reveals Indian small businesses are aggressively implementing sustainability, driven by profit motives, despite a surprising dip in awareness.

JustCo opens its first luxury coworking space in Singapore, unveiling an ambitious plan to double its presence across the Asia-Pacific region by 2029.

The American Academy of Orthopaedic Surgeons awards 14 grants to address a stark diversity crisis in one of medicine's least representative fields.

Publicly traded SUI Group launches its Ethena-backed synthetic dollar and a new yield vault, aiming to lure institutional capital to the Sui blockchain.

Echodyne is building a $40M facility to meet soaring global demand for advanced radar, aiming to counter drone threats and bolster U.S. manufacturing.

Partners Capital closes its largest co-investment fund at over $1B, signaling intense investor appetite for direct private equity deals in the middle market.

With new CEO Dr. Hoshang Subawalla, AquaFortus pivots from R&D to global infrastructure, deploying its disruptive brine tech to rewrite water economics.

A new initiative backed by the Japanese government aims to transform the nation's world-class scientific research into globally competitive biotech companies.